Many researchers are finding that by the time a patient seeks treatment for symptoms of Alzheimer’s disease, it’s often too late for the available drugs to have an effect. Boxer’s lab is studying very precise eye tracking methods to gauge mental fitness and identify cognitive decline decades before the first symptoms appear.
Adam Boxer, MD, PhD
Associate Professor of Neurology
Funding for Boxer’s research is provided by the Alzheimer’s Drug Discovery Foundation, Association for Frontotemporal Degenerations, CurePSP, Hellman Family Foundation, John Douglas French Foundation for Alzheimer’s Research, National Institutes of Health and Tau Research Consortium